120 related articles for article (PubMed ID: 27998907)
1. CC-chemokine class inhibition attenuates pathological angiogenesis while preserving physiological angiogenesis.
Ridiandries A; Tan JT; Ravindran D; Williams H; Medbury HJ; Lindsay L; Hawkins C; Prosser HC; Bursill CA
FASEB J; 2017 Mar; 31(3):1179-1192. PubMed ID: 27998907
[TBL] [Abstract][Full Text] [Related]
2. Broad-spectrum chemokine inhibition blocks inflammation-induced angiogenesis, but preserves ischemia-driven angiogenesis.
Ravindran D; Cartland SP; Bursill CA; Kavurma MM
FASEB J; 2019 Dec; 33(12):13423-13434. PubMed ID: 31574232
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional regulation of angiogenesis by high-density lipoproteins.
Prosser HC; Tan JT; Dunn LL; Patel S; Vanags LZ; Bao S; Ng MK; Bursill CA
Cardiovasc Res; 2014 Jan; 101(1):145-54. PubMed ID: 24130189
[TBL] [Abstract][Full Text] [Related]
4. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
[TBL] [Abstract][Full Text] [Related]
5. Broad-Spectrum Inhibition of the CC-Chemokine Class Improves Wound Healing and Wound Angiogenesis.
Ridiandries A; Bursill C; Tan J
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28098795
[TBL] [Abstract][Full Text] [Related]
6. Opposite angiogenic outcome of curcumin against ischemia and Lewis lung cancer models: in silico, in vitro and in vivo studies.
Fan S; Xu Y; Li X; Tie L; Pan Y; Li X
Biochim Biophys Acta; 2014 Sep; 1842(9):1742-54. PubMed ID: 24970744
[TBL] [Abstract][Full Text] [Related]
7. Adenoviral-mediated delivery of a viral chemokine binding protein blocks CC-chemokine activity in vitro and in vivo.
Bursill CA; Cai S; Channon KM; Greaves DR
Immunobiology; 2003; 207(3):187-96. PubMed ID: 12777060
[TBL] [Abstract][Full Text] [Related]
8. Broad-spectrum CC-chemokine blockade by gene transfer inhibits macrophage recruitment and atherosclerotic plaque formation in apolipoprotein E-knockout mice.
Bursill CA; Choudhury RP; Ali Z; Greaves DR; Channon KM
Circulation; 2004 Oct; 110(16):2460-6. PubMed ID: 15477414
[TBL] [Abstract][Full Text] [Related]
9. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
Forooghian F; Das B
Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
[TBL] [Abstract][Full Text] [Related]
10. A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway.
Sahara M; Sata M; Morita T; Nakajima T; Hirata Y; Nagai R
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1315-24. PubMed ID: 20413734
[TBL] [Abstract][Full Text] [Related]
11. Pseudolaric acid B inhibits angiogenesis and reduces hypoxia-inducible factor 1alpha by promoting proteasome-mediated degradation.
Li MH; Miao ZH; Tan WF; Yue JM; Zhang C; Lin LP; Zhang XW; Ding J
Clin Cancer Res; 2004 Dec; 10(24):8266-74. PubMed ID: 15623602
[TBL] [Abstract][Full Text] [Related]
12. The Role of CC-Chemokines in the Regulation of Angiogenesis.
Ridiandries A; Tan JT; Bursill CA
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834814
[TBL] [Abstract][Full Text] [Related]
13. Gene transfer of a broad spectrum CC-chemokine inhibitor reduces vein graft atherosclerosis in apolipoprotein E-knockout mice.
Ali ZA; Bursill CA; Hu Y; Choudhury RP; Xu Q; Greaves DR; Channon KM
Circulation; 2005 Aug; 112(9 Suppl):I235-41. PubMed ID: 16159823
[TBL] [Abstract][Full Text] [Related]
14. Membrane-bound CC chemokine inhibitor 35K provides localized inhibition of CC chemokine activity in vitro and in vivo.
Bursill CA; Cash JL; Channon KM; Greaves DR
J Immunol; 2006 Oct; 177(8):5567-73. PubMed ID: 17015744
[TBL] [Abstract][Full Text] [Related]
15. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
16. Endothelial deletion of phospholipase D2 reduces hypoxic response and pathological angiogenesis.
Ghim J; Moon JS; Lee CS; Lee J; Song P; Lee A; Jang JH; Kim D; Yoon JH; Koh YJ; Chelakkot C; Kang BJ; Kim JM; Kim KL; Yang YR; Kim Y; Kim SH; Hwang D; Suh PG; Koh GY; Kong YY; Ryu SH
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1697-703. PubMed ID: 24947526
[TBL] [Abstract][Full Text] [Related]
17. Aloe-emodin suppresses hypoxia-induced retinal angiogenesis
Wu J; Ke X; Wang W; Zhang H; Ma N; Fu W; Zhao M; Gao X; Hao X; Zhang Z
Int J Biol Sci; 2016; 12(11):1363-1371. PubMed ID: 27877088
[No Abstract] [Full Text] [Related]
18. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel antiangiogenic anticancer activities of deguelin targeting hypoxia-inducible factor-1 alpha.
Oh SH; Woo JK; Jin Q; Kang HJ; Jeong JW; Kim KW; Hong WK; Lee HY
Int J Cancer; 2008 Jan; 122(1):5-14. PubMed ID: 17764071
[TBL] [Abstract][Full Text] [Related]
20. Site-directed mutagenesis of the CC chemokine binding protein 35K-Fc reveals residues essential for activity and mutations that increase the potency of CC chemokine blockade.
White GE; McNeill E; Christou I; Channon KM; Greaves DR
Mol Pharmacol; 2011 Aug; 80(2):328-36. PubMed ID: 21586597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]